Orasure Tech Inc (OSUR)

$2.31 +0.03 (1.32%)
Market Cap 165.71M
Revenue (ttm) 185.83M
Net Income (ttm) -19.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.49%
Debt to Equity Ratio 0.00
Volume 1,046,300
Avg Vol 521,730
Day's Range N/A - N/A
Shares Out 71.73M
Stochastic %K 21%
Beta 0.54
Analysts Hold
Price Target $3.00

Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rap...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 882 1820
Address:
220 East First Street, Bethlehem, United States
deepthinker
deepthinker Nov. 14 at 3:05 PM
$OSUR I’m glad we decided $4 is a ridiculous undervaluation.
0 · Reply
deepthinker
deepthinker Nov. 14 at 2:48 PM
$OSUR Love the board refresh. So awesome. Great work, guys. Real problem solvers. 🤮
0 · Reply
deepthinker
deepthinker Nov. 13 at 9:01 PM
$OSUR Strong GM’s, but they still run at a massive loss. That tells you all you need to know about management. Any decent team could fix this in no time flat.
0 · Reply
deepthinker
deepthinker Nov. 13 at 7:47 PM
$OSUR As the price sinks, the grift becomes clear for all to see. They rejected a $4 bid knowing full well how badly things were going because they want to keep the paychecks coming. Simple as that. Now, shareholders are giving up because there’s apparently no way out of the maze of death.
0 · Reply
fwank
fwank Nov. 13 at 6:12 PM
$OSUR any insight into the ongoing activist / buyout refusal would be nice as I do some digging on this. @deepthinker seems like he could charge hourly for his knowledge. I’d appreciate an elevator pitch on the value play here.
1 · Reply
deepthinker
deepthinker Nov. 13 at 5:58 PM
$OSUR Ellington Manner and her BoD lackey parasites (Shulkin, Gagliano, Marmora): “It’s our company. We built it for ourselves. We’re not giving it away to anyone just because they’re offering good money. That would hurt our personal incomes!”
0 · Reply
deepthinker
deepthinker Nov. 13 at 5:21 PM
$OSUR The stock will be like 50 cents, “Oh, no, Zwanziger’s $4 all cash bid undervalues the company.” This board is a JOKE.
0 · Reply
deepthinker
deepthinker Nov. 13 at 5:07 PM
$OSUR Newsflash: your board refresh is a total failure. Things are actually getting worse, if that’s even possible.
0 · Reply
deepthinker
deepthinker Nov. 13 at 3:25 PM
$OSUR This probably goes to zero eventually if nothing is done. Carrie Ellington DEI hire Manner will just spend all the money, and that will be that.
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 2:07 PM
Stephens & Co. has adjusted their stance on OraSure Technologies ( $OSUR ), setting the rating to Equal-Weight with a target price of 3.5 → 3.
0 · Reply
Latest News on OSUR
OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 8:11 PM EST - 11 days ago

OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

Oct 29, 2025, 7:30 AM EDT - 18 days ago

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Oct 28, 2025, 4:22 PM EDT - 19 days ago

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Sep 9, 2025, 6:19 AM EDT - 2 months ago

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

Aug 25, 2025, 12:12 PM EDT - 2 months ago

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:17 PM EDT - 3 months ago

OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript

OraSure Appoints Anne Messing as Chief Commercial Officer

Aug 4, 2025, 7:05 AM EDT - 3 months ago

OraSure Appoints Anne Messing as Chief Commercial Officer

OraSure Technologies: An Asymmetric Bet

Jul 28, 2025, 2:43 AM EDT - 4 months ago

OraSure Technologies: An Asymmetric Bet

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

Jul 21, 2025, 4:05 PM EDT - 4 months ago

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

OraSure Technologies received takeover bid from industry entrepreneur, sources say

Jul 14, 2025, 12:03 PM EDT - 4 months ago

OraSure Technologies received takeover bid from industry entrepreneur, sources say

OraSure Launches Novel Blood Collection Device for Proteomic Research

Jul 10, 2025, 7:05 AM EDT - 4 months ago

OraSure Launches Novel Blood Collection Device for Proteomic Research

Orasure Technologies: Multiple Shots To Deliver Value

May 28, 2025, 10:25 AM EDT - 6 months ago

Orasure Technologies: Multiple Shots To Deliver Value

OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript

May 7, 2025, 8:01 PM EDT - 6 months ago

OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript

OraSure Technologies: Historically Cheap

Apr 30, 2025, 3:47 PM EDT - 7 months ago

OraSure Technologies: Historically Cheap

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

Apr 23, 2025, 4:05 PM EDT - 7 months ago

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

OraSure Announces $40 Million Stock Repurchase Program

Mar 24, 2025, 7:30 AM EDT - 8 months ago

OraSure Announces $40 Million Stock Repurchase Program

OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 5:49 AM EST - 9 months ago

OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

Feb 14, 2025, 8:45 AM EST - 9 months ago

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims

Jan 13, 2025, 8:00 AM EST - 10 months ago

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims

OraSure to Present at the J.P Morgan Healthcare Conference

Jan 7, 2025, 4:05 PM EST - 11 months ago

OraSure to Present at the J.P Morgan Healthcare Conference

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 8:50 AM EST - 11 months ago

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 7:05 AM EST - 11 months ago

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraSure Technologies Acquires Sherlock Biosciences

Dec 19, 2024, 4:02 PM EST - 11 months ago

OraSure Technologies Acquires Sherlock Biosciences

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

Dec 11, 2024, 1:34 PM EST - 1 year ago

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

Dec 2, 2024, 7:05 AM EST - 1 year ago

OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

OraSure to Participate in Upcoming Investor Conference

Nov 18, 2024, 4:05 PM EST - 1 year ago

OraSure to Participate in Upcoming Investor Conference

OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:05 PM EST - 1 year ago

OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript

OraSure Reports Q3 '24 Revenue of $39.9 Million

Nov 6, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q3 '24 Revenue of $39.9 Million

OraSure: An NCAV Diamond In The COVID Rough

Nov 4, 2024, 9:32 AM EST - 1 year ago

OraSure: An NCAV Diamond In The COVID Rough

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Oct 22, 2024, 4:05 PM EDT - 1 year ago

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc

Oct 4, 2024, 4:03 PM EDT - 1 year ago

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc

OraSure Technologies Elects Jack Kenny to the Board of Directors

Sep 9, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Elects Jack Kenny to the Board of Directors

OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:04 PM EDT - 1 year ago

OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

Jul 22, 2024, 4:05 PM EDT - 1 year ago

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

OraSure Technologies Supports National HIV Testing Day

Jun 27, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Supports National HIV Testing Day

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

Mar 21, 2024, 8:31 AM EDT - 1 year ago

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 10:16 PM EST - 1 year ago

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Feb 27, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

Feb 13, 2024, 4:05 PM EST - 1 year ago

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

Jan 4, 2024, 7:05 AM EST - 2 years ago

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

OraSure to Participate in Upcoming Investor Conferences

Nov 13, 2023, 4:15 PM EST - 2 years ago

OraSure to Participate in Upcoming Investor Conferences

OraSure Technologies, Inc. (OSUR) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 7:20 PM EST - 2 years ago

OraSure Technologies, Inc. (OSUR) Q3 2023 Earnings Call Transcript

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

Oct 23, 2023, 4:05 PM EDT - 2 years ago

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

OraSure Technologies, Inc. (OSUR) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 11:10 PM EDT - 2 years ago

OraSure Technologies, Inc. (OSUR) Q2 2023 Earnings Call Transcript

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

Aug 3, 2023, 4:05 PM EDT - 2 years ago

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

OraSure Technologies Elects Robert McMahon to the Board of Directors

Jul 20, 2023, 7:05 AM EDT - 2 years ago

OraSure Technologies Elects Robert McMahon to the Board of Directors

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

Jun 13, 2023, 4:05 PM EDT - 2 years ago

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

OraSure: Valuation Upside On The Table At 16x Forward P/E

May 17, 2023, 5:47 AM EDT - 2 years ago

OraSure: Valuation Upside On The Table At 16x Forward P/E

OraSure Technologies: As Good As It Gets

May 15, 2023, 5:57 PM EDT - 2 years ago

OraSure Technologies: As Good As It Gets

deepthinker
deepthinker Nov. 14 at 3:05 PM
$OSUR I’m glad we decided $4 is a ridiculous undervaluation.
0 · Reply
deepthinker
deepthinker Nov. 14 at 2:48 PM
$OSUR Love the board refresh. So awesome. Great work, guys. Real problem solvers. 🤮
0 · Reply
deepthinker
deepthinker Nov. 13 at 9:01 PM
$OSUR Strong GM’s, but they still run at a massive loss. That tells you all you need to know about management. Any decent team could fix this in no time flat.
0 · Reply
deepthinker
deepthinker Nov. 13 at 7:47 PM
$OSUR As the price sinks, the grift becomes clear for all to see. They rejected a $4 bid knowing full well how badly things were going because they want to keep the paychecks coming. Simple as that. Now, shareholders are giving up because there’s apparently no way out of the maze of death.
0 · Reply
fwank
fwank Nov. 13 at 6:12 PM
$OSUR any insight into the ongoing activist / buyout refusal would be nice as I do some digging on this. @deepthinker seems like he could charge hourly for his knowledge. I’d appreciate an elevator pitch on the value play here.
1 · Reply
deepthinker
deepthinker Nov. 13 at 5:58 PM
$OSUR Ellington Manner and her BoD lackey parasites (Shulkin, Gagliano, Marmora): “It’s our company. We built it for ourselves. We’re not giving it away to anyone just because they’re offering good money. That would hurt our personal incomes!”
0 · Reply
deepthinker
deepthinker Nov. 13 at 5:21 PM
$OSUR The stock will be like 50 cents, “Oh, no, Zwanziger’s $4 all cash bid undervalues the company.” This board is a JOKE.
0 · Reply
deepthinker
deepthinker Nov. 13 at 5:07 PM
$OSUR Newsflash: your board refresh is a total failure. Things are actually getting worse, if that’s even possible.
0 · Reply
deepthinker
deepthinker Nov. 13 at 3:25 PM
$OSUR This probably goes to zero eventually if nothing is done. Carrie Ellington DEI hire Manner will just spend all the money, and that will be that.
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 2:07 PM
Stephens & Co. has adjusted their stance on OraSure Technologies ( $OSUR ), setting the rating to Equal-Weight with a target price of 3.5 → 3.
0 · Reply
deepthinker
deepthinker Nov. 10 at 6:54 PM
$OSUR The ever declining stock price indicates that, perhaps, the CEO and her other BoD barnacles have won, and no one will be able to scrape them off the hull. The boat will just slowly sink as the barnacle weight pulls it down to the bottom.
0 · Reply
deepthinker
deepthinker Nov. 7 at 4:31 PM
$OSUR Just a thought: this earnings report was so bad, and as there is little to no prospect that things will improve much, there is really no basis to claim that $4 is somehow undervalued.
1 · Reply
SuperGreenToday
SuperGreenToday Nov. 7 at 2:55 PM
$OSUR Share Price: $2.40 Contract Selected: Apr 17, 2026 $2.5 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.88 – $1.08 Potential Upside: 78% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
d_risk
d_risk Nov. 6 at 4:06 PM
$OSUR - OraSure Technologies Inc. Common Stock - 10Q - Updated Risk Factors OSUR warns that FDA or government agency staffing and funding shortages could delay product development, commercialization, and regulatory processes, potentially impacting business operations and timelines. #MedicalDevices #GovernmentFunding #ProductDevelopment #FDADelays #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/OSUR/10-Q/2025-11-05
0 · Reply
deepthinker
deepthinker Nov. 6 at 2:43 PM
$OSUR Absolute crap show.
0 · Reply
deepthinker
deepthinker Nov. 6 at 2:31 PM
$OSUR Ha-ha $2.30. All time low. Shall we do another board refresh🤣?
0 · Reply
deepthinker
deepthinker Nov. 6 at 2:08 PM
$OSUR My guess is they’ll put Kenny is as “interim” CEO as a way to…do something. They can’t keep DEI hire Eglinton Beachhouse Henhouse Two Car Garage Mannor around any more. She’s incapable of turning this around.
0 · Reply
deepthinker
deepthinker Nov. 6 at 1:08 PM
$OSUR I look forward to RZ’s next move. This BoD has got no rationale for rejecting a decent offer after yet another terrible report. They can open it up to bidding, but they can’t just do nothing any longer.
0 · Reply
deepthinker
deepthinker Nov. 6 at 1:54 AM
$OSUR I doubt all their little tricks will throw activists off the rotten trail. Carrie Eglinton Duplex Brickhouse Outhouse Manner will be ousted from her unearned feathered nest soon enough.
0 · Reply
Gantz7
Gantz7 Nov. 5 at 10:33 PM
$OSUR Oh , we doing stuff now...!!!
0 · Reply
deepthinker
deepthinker Nov. 5 at 9:54 PM
$OSUR I don’t see how they ignore activists and active bids. Are there shareholders clamoring for this management to continue. I doubt it. They also can’t sub in some fresh BoD yes-men and expect that to be the end of it.
0 · Reply
deepthinker
deepthinker Nov. 5 at 9:25 PM
$OSUR Yeah, is someone still offering $3.50?
0 · Reply